V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310005037 | 310002289 | null | 83 | Not known (9) | 2015-01-26 | 2015-02-04 | BEP 3 day | 02 | N | 310025231 | CAPECITABINE + CARBOPLATIN |
| 310005038 | 310002290 | 1.55 | 65.4 | Palliative (P) | 2013-10-24 | 2013-10-25 | Fluorouracil+Mitomycin+RT (Anal Ca) | 2 | N | 310025251 | CISPLATIN + PEMETREXED |
| 310005039 | 310002291 | 1.83 | 71.4 | Palliative (P) | 2015-04-03 | 2015-04-14 | Vinblastine | N | N | 310025252 | CVP R + GEMCITABINE |
| 310005040 | 310002292 | 1.68 | 87.7 | Curative (C) | 2013-10-01 | 2013-10-16 | CYCLOPHOSPHAMIDE | 99 | N | 310025263 | NIVOLUMAB |
| 310005041 | 310002293 | 1.73 | 80.1 | Curative (C) | 2015-05-23 | 2015-06-06 | BLEOMYCIN | 02 | N | 310025266 | BEP |
| 310005042 | 310006952 | 1.67 | 66.6 | Palliative (P) | 2014-06-29 | 2015-02-05 | Cisplatin + Etoposide + RT | N | N | 310025272 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 310005043 | 310002294 | 1.83 | 88.4 | Disease modification (D) | 2015-10-26 | 2015-11-10 | IVE | N | N | 310025289 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN |
| 310005044 | 310002295 | 1.85 | 71 | Curative (C) | 2013-04-26 | 2013-04-30 | Capecitabine + Cisplatin + RT | N | N | 310025291 | RCEOP |
| 310005045 | 310002295 | 1.65 | 59 | Curative (C) | 2013-05-12 | 2013-05-14 | CARBO + ETOPOSIDE + VINCRISTINE | N | null | 310025291 | CARBOPLATIN + VINORELBINE |
| 310005046 | 310002296 | 1.57 | 81 | Adjuvant (A) | 2015-11-22 | 2015-11-23 | ECF | 02 | N | 310025295 | CARBOPLATIN + RT |
| 310005047 | 310002297 | null | 68 | Neo-adjuvant (N) | null | 2017-09-08 | Ifosfamide PVI 1g/m2 14day | N | null | 310025315 | IVE |
| 310005048 | 310002297 | 1.52 | 65 | Disease modification (D) | 2017-10-29 | 2017-10-30 | Carboplatin+Fluorouracil 4 or 5 day | 2 | N | 310025315 | RUXOLITINIB |
| 310005049 | 310002298 | 1.62 | 60.3 | Disease modification (D) | 2013-11-29 | 2013-12-01 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | N | 310025319 | EVEROLIMUS |
| 310005050 | 310002299 | 1.62 | 50.6 | Curative (C) | 2013-04-06 | 2013-05-02 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | N | 310025333 | CYCLO + ETOPOSIDE + VINCRISTINE |
| 310005051 | 310002299 | 1.7 | 65.4 | Palliative (P) | 2015-10-10 | 2015-10-14 | Chlorambucil | N | N | 310025333 | OXALIPLATIN |
| 310005052 | 310002300 | null | 57.5 | null | 2015-09-21 | 2015-10-07 | CAPECITABINE + GEMCITABINE | null | N | 310025341 | DOXORUBICIN + OLARATUMAB |
| 310005053 | 310002300 | null | 109 | null | 2015-06-10 | 2015-06-24 | Docetaxel 75mg/m2 (21 day) | N | N | 310025341 | ECARBOX |
| 310005054 | 310002301 | 1.52 | 75 | Palliative (P) | 2015-03-23 | 2015-03-24 | DHAP | N | N | 310025352 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310005055 | 310002301 | 1.66 | 60.1 | Palliative (P) | 2018-04-04 | 2018-04-15 | GEMCITABINE + VINORELBINE | 02 | N | 310025352 | OXALIPLATIN |
| 310005056 | 310002302 | null | null | null | 2014-06-05 | 2014-06-09 | Cisplatin + Topotecan | N | N | 310025363 | CVP |
| 310005057 | 310002303 | 1.65 | 83 | Neo-adjuvant (N) | 2013-10-26 | 2013-11-13 | Atezolizumab | N | N | 310025368 | CAPECITABINE + CISPLATIN + RT |
| 310005058 | 310002304 | 1.58 | null | Curative (C) | 2017-01-22 | 2017-01-22 | OCTREOTIDE | 01 | N | 310025372 | BEVACIZUMAB |
| 310005059 | 310002305 | null | 129 | Disease modification (D) | null | 2015-12-17 | POUT TRIAL | 2 | null | 310025373 | METHOTREXATE |
| 310005060 | 310002306 | 1.6 | null | Palliative (P) | 2016-08-08 | 2016-08-15 | CYCLOPHOSPHAMIDE + ETOPOSIDE + VINCRISTINE | 02 | N | 310025375 | FEC |
| 310005061 | 310002306 | 1.5 | 80 | Adjuvant (A) | 2016-05-18 | 2016-05-19 | CAPECITABINE + TEMOZOLOMIDE | 2 | N | 310025375 | ALEMTUZUMAB |
| 310005062 | 310002307 | 0 | 78.5 | Adjuvant (A) | 2015-05-30 | 2015-05-30 | CMV | 2 | N | 310025377 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310005063 | 310002308 | null | 65.9 | Curative (C) | 2017-05-10 | 2017-05-12 | Gemcitabine + Oxaliplatin | Y | N | 310025385 | CISPLATIN + FLUOROURACIL + RT |
| 310005064 | 310006959 | 1.64 | null | Disease modification (D) | 2013-09-07 | 2013-09-08 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 310025395 | CYCLOPHOSPHAMIDE |
| 310005065 | 310006959 | null | 71 | Palliative (P) | 2017-10-14 | 2017-10-18 | ECarboX | N | Y | 310025395 | IVE |
| 310005066 | 310002309 | 1.65 | 99.7 | Curative (C) | 2016-06-18 | 2016-06-18 | SelPac Trial | Y | N | 310025411 | ENZALUTAMIDE |
| 310005067 | 310002309 | 1.57 | null | null | null | 2014-02-17 | EC | N | null | 310025411 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 310005068 | 310002310 | 1.6 | 0 | Palliative (P) | 2016-01-01 | 2016-01-02 | ESHAP | N | N | 310025414 | FLAG + IDARUBICIN |
| 310005069 | 310002310 | 1.8 | 75 | Palliative (P) | 2016-06-03 | 2016-06-09 | ALL UKALL2011 Maintenance B4 | N | N | 310025414 | CHLORAMBUCIL |
| 310005070 | 310002311 | 1.79 | null | Curative (C) | 2014-05-22 | 2014-05-30 | BEP 5 Day | N | N | 310025420 | SELPAC TRIAL |
| 310005071 | 310002312 | 1.73 | 23.6 | Curative (C) | null | 2017-06-16 | Folfirinox | 02 | N | 310025436 | CRIZOTINIB |
| 310005072 | 310006962 | null | null | Palliative (P) | 2017-09-27 | 2017-09-29 | METHOTREXATE | N | N | 310025439 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 310005073 | 310002313 | 1.63 | null | Palliative (P) | 2015-10-20 | 2015-11-01 | CARBOPLATIN + RT | N | N | 310025463 | METHOTREXATE |
| 310005074 | 310002314 | 1.7 | 68 | Curative (C) | 2016-03-03 | 2016-03-04 | Capecitabine + Cisplatin + RT | N | N | 310025468 | LANREOTIDE |
| 310005075 | 310002314 | 0 | 75.7 | Palliative (P) | 2014-07-26 | 2014-08-07 | GDP | N | N | 310025468 | PEG INTERFERON |
| 310005076 | 310002314 | 1.59 | 0 | Palliative (P) | 2013-10-16 | 2013-10-22 | Chlorambucil | N | N | 310025468 | CYCLOPHOSPHAMIDE + GEMCITABINE + VINCRISTINE |
| 310005077 | 310002314 | null | 78.5 | null | 2016-09-04 | 2016-09-11 | Chlorambucil | N | null | 310025468 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE |
| 310005078 | 310002314 | 1.63 | 70.3 | Curative (C) | 2016-05-13 | 2016-05-23 | Carboplatin + Liposomal Doxorubicin | N | N | 310025468 | CVP R |
| 310005079 | 310002315 | null | 77 | Curative (C) | 2017-01-18 | 2017-01-23 | METHOTREXATE | Y | N | 310025515 | FLUOROURACIL |
| 310005080 | 310002316 | 1.68 | 82 | Curative (C) | 2014-05-29 | 2014-05-31 | Cisplatin + Fluorouracil + RT 5day | N | N | 310025516 | NILOTINIB |
| 310005081 | 310002317 | 1.69 | 0 | Adjuvant (A) | 2017-04-07 | 2017-04-12 | IDARAM | N | N | 310025528 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE |
| 310005082 | 310002318 | 1.68 | null | Neo-adjuvant (N) | 2016-08-24 | 2016-08-25 | R GCVP | null | N | 310025530 | CVP R |
| 310005083 | 310002319 | 1.63 | null | Palliative (P) | 2015-08-27 | 2015-11-11 | EOF | 2 | Y | 310025547 | BEP |
| 310005084 | 310002319 | 1.73 | 65.4 | Palliative (P) | 2017-03-30 | 2017-04-28 | Docetaxel | 02 | N | 310025547 | IFOSFAMIDE |
| 310005085 | 310002320 | 1.8 | 84.45 | null | 2014-01-29 | 2014-07-10 | DABRAFENIB | N | N | 310025578 | HCX |
| 310005086 | 310002321 | 1.67 | 88.5 | Palliative (P) | 2017-10-31 | 2017-10-31 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 310025604 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |